Borstkanker Onderzoek Groep

Borstkanker Onderzoek Groep (BOOG) is the leading Dutch clinical research organization dedicated to the advancement of breast cancer treatment and care. Founded in 2001, the foundation initiates, coordinates, and promotes high-quality clinical trials across a collaborative network involving nearly all Dutch hospitals. BOOG facilitates multicenter studies ranging from Phase I to Phase III, focusing on optimizing therapeutic strategies such as targeted therapies, immunotherapies, and de-escalation protocols. The organization acts as a critical bridge between academic innovation and clinical practice, ensuring that research findings are rapidly integrated into standard patient care. As a member of the Breast International Group (BIG), BOOG also participates in significant international collaborative research efforts that shape global treatment guidelines.